The findings in this publication demonstrate that the gram-negative intracellular bacterial pathogen Shigella flexneri, which…
eabramovichDecember 2, 2020
Over the past few years, medical scientists have been using 3D printing to create artificial…
eabramovichDecember 1, 2020
A combination cancer therapy that is effective against treatment-resistant hepatocellular carcinoma (HCC) by inhibiting tumor…
eabramovichDecember 1, 2020
Nanoparticles are promising drug delivery tools, offering the ability to administer drugs directly to a…
eabramovichNovember 30, 2020
Alcohol use disorder impacts millions of people around the world, including at least 17 million…
eabramovichNovember 30, 2020
CD39 is an ectonucleotidase that initiates conversion of extracellular nucleotides into immunosuppressive adenosine. CD39 is…
eabramovichNovember 27, 2020
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer, today…
eabramovichNovember 27, 2020
Six Harvard Medical School scientists and clinicians have been elected by their peers as 2020 Fellows…
eabramovichNovember 26, 2020
Favoritism or impartiality? Do the four genomic subtypes of melanoma have a bias toward certain…
eabramovichNovember 26, 2020
